# Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-double-blind-phase-ii-study-of-temozolomide-in-combination-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | M. Catherine Pietanza,Saiama N. Waqar,Lee M. Krug,Afshin Dowlati,Christine L. Hann,Alberto Chiappori,Taofeek K. Owonikoko,Kaitlin M. Woo,Robert J. Cardnell,Junya Fujimoto,Lihong Long,Lixia Diao,Jing Wang,Yevgeniva Bensman,Brenda Hurtado,Patricia M. de Groot,Erik P. Sulman,Ignacio I. Wistuba,Alice P. Chen,Martin Fleisher,John V. Heymach,Mark G. Kris,Charles M. Rudin,Lauren A. Byers |
| Citations | 404 |
| DOI | 10.1200/jco.2018.77.7672 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1200/jco.2018.77.7672 |
| OpenAlex ID | https://openalex.org/W2808238124 |
| PMID | 29906251 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Afshin Dowlati](https://scholariq.org/researchers/afshin-dowlati/)
- [Mark G. Kris](https://scholariq.org/researchers/mark-g-kris/)
- [John V. Heymach](https://scholariq.org/researchers/john-v-heymach/)
- [Charles M. Rudin](https://scholariq.org/researchers/charles-m-rudin/)
- [Alberto Chiappori](https://scholariq.org/researchers/alberto-chiappori/)
- [Jing Wang](https://scholariq.org/researchers/jing-wang-2/)
- [Lauren A. Byers](https://scholariq.org/researchers/lauren-a-byers/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.